Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 5
2007 2
2008 2
2009 2
2010 6
2011 4
2012 5
2013 7
2014 11
2015 9
2016 6
2017 10
2018 11
2019 16
2020 20
2021 12
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Results by year
Filters applied: . Clear all
Page 1
Telomerase-Targeted Cancer Immunotherapy.
Mizukoshi E, Kaneko S. Mizukoshi E, et al. Among authors: kaneko s. Int J Mol Sci. 2019 Apr 12;20(8):1823. doi: 10.3390/ijms20081823. Int J Mol Sci. 2019. PMID: 31013796 Free PMC article. Review.
Immune cell therapy for hepatocellular carcinoma.
Mizukoshi E, Kaneko S. Mizukoshi E, et al. Among authors: kaneko s. J Hematol Oncol. 2019 May 29;12(1):52. doi: 10.1186/s13045-019-0742-5. J Hematol Oncol. 2019. PMID: 31142330 Free PMC article. Review.
A liver-derived secretory protein, selenoprotein P, causes insulin resistance.
Misu H, Takamura T, Takayama H, Hayashi H, Matsuzawa-Nagata N, Kurita S, Ishikura K, Ando H, Takeshita Y, Ota T, Sakurai M, Yamashita T, Mizukoshi E, Yamashita T, Honda M, Miyamoto K, Kubota T, Kubota N, Kadowaki T, Kim HJ, Lee IK, Minokoshi Y, Saito Y, Takahashi K, Yamada Y, Takakura N, Kaneko S. Misu H, et al. Among authors: mizukoshi e, kaneko s. Cell Metab. 2010 Nov 3;12(5):483-95. doi: 10.1016/j.cmet.2010.09.015. Cell Metab. 2010. PMID: 21035759 Free article.
Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis.
Ho TTB, Nasti A, Seki A, Komura T, Inui H, Kozaka T, Kitamura Y, Shiba K, Yamashita T, Yamashita T, Mizukoshi E, Kawaguchi K, Wada T, Honda M, Kaneko S, Sakai Y. Ho TTB, et al. Among authors: mizukoshi e, kaneko s. J Immunother Cancer. 2020 Nov;8(2):e001367. doi: 10.1136/jitc-2020-001367. J Immunother Cancer. 2020. PMID: 33188035 Free PMC article.
Management of biliary stricture in patients with IgG4-related sclerosing cholangitis.
Miyazawa M, Takatori H, Kawaguchi K, Kitamura K, Arai K, Matsuda K, Urabe T, Inamura K, Komura T, Mizuno H, Fuchizaki U, Yamashita T, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Kaneko S. Miyazawa M, et al. Among authors: mizukoshi e, kaneko s. PLoS One. 2020 Apr 30;15(4):e0232089. doi: 10.1371/journal.pone.0232089. eCollection 2020. PLoS One. 2020. PMID: 32353060 Free PMC article.
Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinoma.
Terashima T, Yamashita T, Takata N, Takeda Y, Kido H, Iida N, Kitahara M, Shimakami T, Takatori H, Arai K, Kawaguchi K, Kitamura K, Yamashita T, Sakai Y, Mizukoshi E, Honda M, Kaneko S. Terashima T, et al. Among authors: mizukoshi e, kaneko s. Hepatol Res. 2021 Feb;51(2):190-200. doi: 10.1111/hepr.13588. Epub 2020 Dec 4. Hepatol Res. 2021. PMID: 33197087
Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma.
Hashiba T, Yamashita T, Okada H, Nio K, Hayashi T, Asahina Y, Hayashi T, Terashima T, Iida N, Takatori H, Shimakami T, Kawaguchi K, Arai K, Sakai Y, Yamashita T, Mizukoshi E, Takamura H, Ohta T, Honda M, Kaneko S. Hashiba T, et al. Among authors: mizukoshi e, kaneko s. Cell Mol Gastroenterol Hepatol. 2020;10(2):269-285. doi: 10.1016/j.jcmgh.2020.02.009. Epub 2020 Mar 10. Cell Mol Gastroenterol Hepatol. 2020. PMID: 32169577 Free PMC article.
118 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page